白人和黑人美国人的心脏代谢障碍和轻度认知障碍
Voyko Kavcic1, Mohammad Turaani2, Subhamoy Pal3,4
1Institute of Gerontology, Wayne State University, Detroit, Michigan, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|September 9, 2025
概括
轻度认知障碍 (MCI) 与心血管问题有关. 与正常人相比,amnestic MCI (aMCI) 患者的高血压和糖尿病的发病率更高. 种族和诊断影响MCI护理和痴呆风险.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 轻度认知障碍 (MCI) 是正常衰老和痴呆症之间的关键阶段.
- 心血管和代谢障碍是认知能力下降的潜在危险因素.
- 了解这些关联对于早期诊断和干预至关重要.
研究的目的:
- 研究心血管/代谢疾病与不同MCI亚型之间的关联.
- 检查MCI个体在并发症负担中的种族差异.
- 确定与增加并发症风险相关的人口和健康因素.
主要方法:
- 来自国家阿尔茨海默氏症协调中心 (NACC) 数据库的大型队列 (N=8737) 的分析.
- 用多项逻辑回归模型来评估关联.
- 对人口统计和与健康有关的变量进行控制的数据.
主要成果:
- 与认知上正常的个体相比,患有无记忆性MCI (aMCI) 的个体患高血压,糖尿病和高脂血症的可能性更高.
- 在aMCI和非amnestic MCI (naMCI) 亚型之间没有发现并发症负担的显著差异.
- 黑人美国人,无论认知状态如何,与白人美国人相比,高血压和糖尿病的发病率更高.
结论:
- 诊断和种族是MCI管理和护理的关键因素.
- 需要量身定制的干预措施来解决健康不平等问题,并减少痴呆症进展风险.
- 年龄较大,男性性别,BMI较高和教育程度较低都与伴随性疾病风险增加有关.
相关概念视频
Coronary Artery Disease I: Introduction
893
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
893
Cognitive Development During Adulthood
792
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
792
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
563
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
563
Overview of Carbohydrate Metabolism
3.3K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.3K


